neonates Flashcards
nitric oxide therapy
- must be >34 weeks gestation
- initial dose= 20ppm
- must be weaned to prevent rebound
- causes methemoglinemia
*pulm vasodilator
PPHN treatment
- hyperventilation
- alkaine pH
- sodium bicarb to produce alkalemia
- inhaled nitric oxide
- tolazoline
- nitroprusside sodium
- dopamine`
IRDS treatment
- O2 therapy
- if pH <7.25
- surfactant replacement
- thermoregulation
transcutaneous PaCO2/O2 monitoring
- warms site to 43-45C
- site should be changed every 2-6hrs
- frequent calibration
umbilical artery catheter complications
- infection
- thromboembolism
- air embolism
- hemorrhage
* use for no longer than 7 days
nasal cannulas
- for long term therapy
2. work in increments of 0.25/0.50
air-blender systems
incorporate
- alarm module
- pressure-balancing module
- proportioning module
oxygen mist tent
tx of croup
21%-50% range
10-15L/min
O2 hood
- provides 21%-100% O2
2. flows of at least 5L.min to prevent CO2 buildup
APGAR evaluation
Appearance (color) Pulse (HR) Grimace (reflex irritability) Activity (muscle tone) Respiration (RR)
maternal factors involved w high risk infants
- age
- diabetes
- drug/alcohol/tabacoo
- infections
- previousu c section
- prior birth w respiratory prblems
- lack of prenatal care
causes of high risk infants
- PROM
- premature delivery
- postmature delivery
- meconium in amniotic fluid
- prolapsed cord
- prolonged labor
- abnormal fetal presentation
central cyanosis
- mucus membranes/tongue/lips
2. must administer O2 immediately
normal pulse (HR)
110-160 beats per min
normal RR
30-60 breaths per min
normal BP
60/40
apneic periods
apnea of 10secs or more is abnormal
transcutaneous error
airleaks will show higher PO2, lower PCO2
capillary O2
PO2 values are normally lower than arterial PO2
normal PCO2 is 40-50